Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06840288 · ClinicalTrials.gov registry record
Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
A clinical trial of Thoracic Tumors, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT06840288 is a study of Thoracic Tumors that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 250 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06840288, a study of Thoracic Tumors, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.
Conditions Studied
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-02-19 |
| Est. Completion | 2036-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06840288
The ClinicalTrials.gov registry entry for NCT06840288 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thoracic Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT06840288 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06840288 about?
NCT06840288 is a clinical study titled "Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry". To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.
What is the current status of trial NCT06840288?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-02-19. Estimated completion is 2036-12-31.
What conditions does trial NCT06840288 study?
This clinical trial studies the following conditions: Thoracic Tumors.
Who is sponsoring clinical trial NCT06840288?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06840288 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracic Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.